Post-earnings recap
Reported
Thu, Nov 3, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Corvus Pharmaceuticals reported a loss of $0.51 per share, but the stock rose by 3.89% following the earnings announcement. The increase in stock price may reflect investor sentiment or market conditions rather than specific performance metrics, as no revenue figures were provided and no guidance was issued.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.51 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record for the earnings call, so the analysis is based solely on numerical results.